Comprehensive Hereditary Cancer Panel

Comprehensive Hereditary Cancer Panel

The Multiplicom BRCA Hereditary Cancer MASTR Plus is a molecular assay for the identification of all mutations and CNVs in 26 key oncogenes associated with hereditary breast, ovarian and other related cancers.

The panel consists of 6-high (including BRCA 1, BRCA 2), 9-medium and 11-low genes penetrance according to appropriate patient population on high-risk assessment with the inherited targeted cancer syndromes.

Contact us

NewGene Limited
Bioscience Building
International Centre for Life
Newcastle upon Tyne
NE1 4EP, UK

Tel: +44 (0)191 242 1923
Fax: +44 (0)191 241 8799
Email: info@newgene.org.uk

Click here for location map

Mon – Fri 08:30 to 17:00, closed Bank Holidays

An ISO 15189 accredited Medical Laboratory company

NewGene Limited | Company Number: 06735445

Technology Partners

Agilent Technologies

Agena Bioscience

Illumina

Sophia Genetics

Qiagen

Promega

Enquiry form